Greenleaf Trust’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$206K Sell
430
-1
-0.2% -$512 ﹤0.01% 769
2025
Q4
$242K Buy
431
+5
+1% +$2.84K ﹤0.01% 728
2025
Q3
$219K Buy
+426
New +$186K ﹤0.01% 752

Other funds holding MEDP

Greenleaf Trust's MEDP Position: Q1 2026 in Review

Greenleaf Trust reduced its Medpace (MEDP) stake by 0.23% in Q1 2026, selling an estimated $512 and leaving 430 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #769.

Greenleaf Trust first reported a position in MEDP in Q3 2025 and has held it in 3 quarters since. The position peaked at $242K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Greenleaf Trust held 430 shares of Medpace worth $206K as of Q1 2026.
  • Greenleaf Trust sold 1 Medpace share in Q1 2026, an estimated $512.
  • Medpace made up ﹤0.01% of Greenleaf Trust's portfolio in Q1 2026, its #769 holding.
  • Greenleaf Trust first reported a position in Medpace in Q3 2025 and has held it in 3 quarters since.
  • Greenleaf Trust's Medpace position peaked at $242K in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.